Nova provides its jinkō clinical trials simulation platform to biotech and pharma companies, academic research centers and not-for-profit organizations.
Jinkō® unlocks the potential of modeling & simulation to de-risk and accelerate the R&D of new therapies for the benefit of patients: identify best responders, optimise the drug's regimen, generate synthetic control arms, explore research outcomes that might not be feasible with conventional trials.
Predict trial outcomes before advancing to real-world clinical trials and ultimately design studies that are more likely to succeed with Jinkō®.
Company Details
- Employees
- 60
- Founded
- -
- Address
- 1 Place Giovanni Da Verrazzano, Lyon,rhône 69009,france
- Industry
- Software Development
- NAICS
-
Software Publishers
- Website
- novadiscovery.com
- Keywords
- Pharmaceutical R&D, Computer Sciences, In silico clinical trials, Clinical pharmacology, QSP, PK/PD, Quantitative clinical pharmacology, Systems biology, Pharmacometrics.
- HQ
- Lyon, Rhône
Nova In Silico Questions
Nova In Silico's website is novadiscovery.com
Nova In Silico's LinkedIn profile is https://fr.linkedin.com/company/novainsilico
Nova In Silico has
60 employees.
View email and phone details for 60
employees at Nova In Silico.
Nova In Silico's industry is
Software Development
Nova In Silico's top competitors are
Moona.health,
Scope Impact,
Bc Platforms,
Botdesign,
Modirum Platforms,
Cline Research,
Life & Soft,
Rime Bioinformatics,
Skezi,
Insilicotrials.
Nova In Silico's categories are Software Development
Nova In Silico's founding year is 2010
